HRP20020665A2 - Composition - Google Patents

Composition Download PDF

Info

Publication number
HRP20020665A2
HRP20020665A2 HRP20020665A HRP20020665A2 HR P20020665 A2 HRP20020665 A2 HR P20020665A2 HR P20020665 A HRP20020665 A HR P20020665A HR P20020665 A2 HRP20020665 A2 HR P20020665A2
Authority
HR
Croatia
Prior art keywords
compound
group
ring
sulfamate
composition according
Prior art date
Application number
Other languages
English (en)
Croatian (hr)
Inventor
Barry Victor Lloyd Potter
Michael John Reed
Walter Elger
Gudrun Roddersen
Heinrich-Thomas Proske
Original Assignee
Sterix Ltd
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0000792A external-priority patent/GB0000792D0/en
Priority claimed from GB0002115A external-priority patent/GB0002115D0/en
Application filed by Sterix Ltd, Schering Ag filed Critical Sterix Ltd
Publication of HRP20020665A2 publication Critical patent/HRP20020665A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20020665 2000-01-14 2001-01-11 Composition HRP20020665A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0000792A GB0000792D0 (en) 2000-01-14 2000-01-14 Composition
GB0002115A GB0002115D0 (en) 2000-01-28 2000-01-28 Composition
US21873000P 2000-07-17 2000-07-17
PCT/GB2001/000094 WO2001051055A2 (en) 2000-01-14 2001-01-11 Pharmaceutical compositions containing steroidal structures and uses thereof

Publications (1)

Publication Number Publication Date
HRP20020665A2 true HRP20020665A2 (en) 2004-12-31

Family

ID=27255470

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20020665 HRP20020665A2 (en) 2000-01-14 2001-01-11 Composition

Country Status (26)

Country Link
EP (1) EP1248626B1 (de)
JP (1) JP2003519658A (de)
KR (1) KR20020087930A (de)
CN (1) CN1404394A (de)
AR (1) AR028196A1 (de)
AT (1) ATE332140T1 (de)
AU (1) AU2533101A (de)
BG (1) BG106914A (de)
BR (1) BR0107630A (de)
CA (1) CA2396098A1 (de)
CO (1) CO5280199A1 (de)
CZ (1) CZ20022282A3 (de)
DE (1) DE60121293T2 (de)
EE (1) EE200200391A (de)
ES (1) ES2267707T3 (de)
HR (1) HRP20020665A2 (de)
HU (1) HUP0300887A2 (de)
IL (1) IL150471A0 (de)
MX (1) MXPA01000464A (de)
NO (1) NO20023392L (de)
PE (1) PE20011121A1 (de)
PL (1) PL357020A1 (de)
SK (1) SK10022002A3 (de)
TR (1) TR200100070A3 (de)
UY (1) UY26530A1 (de)
WO (1) WO2001051055A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
EP1358882A1 (de) * 2002-04-30 2003-11-05 Schering Aktiengesellschaft Verwendung von Prodrogue von Estriol sulfamate zur Behandlung von autoimmunischen Erkrankungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
KR200449618Y1 (ko) * 2008-01-16 2010-07-23 주식회사 코비스 스포츠 그린보수기
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
US11253498B2 (en) * 2017-06-01 2022-02-22 Nexyon Biotech Co., Ltd. Pharmaceutical composition for treatment of bone-related disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen

Also Published As

Publication number Publication date
EE200200391A (et) 2003-12-15
CZ20022282A3 (cs) 2002-11-13
AU2533101A (en) 2001-07-24
NO20023392L (no) 2002-09-16
BR0107630A (pt) 2002-10-08
PL357020A1 (en) 2004-07-12
HUP0300887A2 (hu) 2003-07-28
WO2001051055A3 (en) 2002-03-21
SK10022002A3 (sk) 2002-12-03
PE20011121A1 (es) 2001-11-05
DE60121293D1 (de) 2006-08-17
AR028196A1 (es) 2003-04-30
TR200100070A2 (tr) 2001-08-21
JP2003519658A (ja) 2003-06-24
CN1404394A (zh) 2003-03-19
CO5280199A1 (es) 2003-05-30
BG106914A (en) 2003-01-31
WO2001051055A2 (en) 2001-07-19
ES2267707T3 (es) 2007-03-16
EP1248626B1 (de) 2006-07-05
IL150471A0 (en) 2002-12-01
EP1248626A2 (de) 2002-10-16
ATE332140T1 (de) 2006-07-15
KR20020087930A (ko) 2002-11-23
DE60121293T2 (de) 2007-06-28
TR200100070A3 (tr) 2001-08-21
MXPA01000464A (es) 2003-07-21
NO20023392D0 (no) 2002-07-12
UY26530A1 (es) 2001-07-31
CA2396098A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
US7893284B2 (en) Oestrogen derivatives as inhibitors of steroid sulphatase
US6653298B2 (en) Composition
US7335650B2 (en) Composition
JP5074655B2 (ja) ステロイドスルファターゼの阻害剤としての１７−アリール−リンカー誘導体化エストロゲン３−スルファメート
US7342004B2 (en) Thioether sulphamate steroids as steroid inhibitors and anti-cancer compounds
WO2002032409A2 (en) Use of compound in the manufacture of a pharmaceutical for inhibiting steroid sulphatase and steroid dehydrogenase activity
EP1248626B1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
JP4931312B2 (ja) ステロイドスルファターゼのインヒビターとしてのハロゲン化スルファメート−、ホスホネート−、チオホスホネート−、スルホネート−、およびスルホンアミド−化合物
JP2005506359A (ja) ステロイドスルファターゼを阻害するための、ステロイド化合物
EP1769799A2 (de) Pharmazeutische Zusammensetzung, welche steroidische Strukturen enthalten, und deren Verwendungen
HK1082258B (en) Oestrogen derivatives as inhibitors of steroid sulphatase

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn